Protease-activated receptor-2 (PAR-2) in the pancreas and parotid gland: Immunolocalization and involvement of nitric oxide in the evoked amylase secretion

Life Sciences

Volumn 71, Issue 20, 2002, Pages 2435-2446

  Kawabata, Atsufumi ^a   Kuroda, Ryotaro ^a   Nishida, Minoru ^b   Nagata, Nanae ^a   Sakaguchi, Yuriko ^a   Kawao, Naoyuki ^a   Nishikawa, Hiroyuki ^b   Arizono, Naoki ^c   Kawai, Kenzo ^b  

^a KINKI UNIVERSITY   (Japan)

^b Fuso Pharmaceutical Industries Ltd   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Amylase secretion; Nitric oxide (NO); Pancreas; Parotid gland; Protease activated receptor 2 (PAR 2)

Indexed keywords

AMASTATIN; AMYLASE; CAPSAICIN; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POLYCLONAL ANTIBODY; POLYPEPTIDE; PROTEINASE ACTIVATED RECEPTOR 2; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINAMIDE; UNCLASSIFIED DRUG;

ACINAR CELL; AMYLASE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IN VIVO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; PANCREAS; PANCREAS SECRETION; PAROTID GLAND; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SALIVATION; SENSORY NERVE CELL;

AMINO ACID SEQUENCE; AMYLASES; ANIMALS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MOLECULAR SEQUENCE DATA; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PANCREAS; PAROTID GLAND; RATS; RATS, WISTAR; RECEPTOR, PAR-2; RECEPTORS, THROMBIN;

RICKETTSIA SP. PAR;

EID: 0037019916     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02044-1     Document Type: Article

References (43)

1. Nystedt S., Emilsson K., Wahlestedt C., Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proceedings of National Academy of Sciences of U.S.A. 91:1994;9208-9212.
2. Dery O., Corvera C.U., Steinhoff M., Bunnett N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. American Journal of Physiology. 274:1998;C1429-C1452.
3. Hollenberg M.D. Protease-activated receptors: PAR-4 and counting: how long is the course. Trends in Pharmacological Sciences. 20:1999;271-273.
4. Kawabata A., Kuroda R. Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. Japanese Journal of Pharmacology. 82:2000;171-174.
5. Molino M., Barnathan E.S., Numerof R., Clark J., Dreyer M., Cumashi A., Hoxie J.A., Schechter N., Woolkalis M., Brass L.F. Interactions of mast cell tryptase with thrombin receptors and PAR-2. Journal of Biological Chemistry. 272:1997;4043-4049.
6. Camerer E., Huang W., Coughlin S.R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proceedings of National Academy of Sciences of U.S.A. 97:2000;5255-5260.
7. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., Ennes H.S., Trevisani M., Hollenberg M.D., Wallace J.L., Caughey G.H., Mitchell S.E., Williams L.M., Geppetti P., Mayer E.W., Bunnett N.W. Agonists of proteinase-activated receptor-2 induce inflammation by a neurogenic mechanism. Nature Medicine. 6:2000;151-158.
8. Kawabata A., Kawao N., Kuroda R., Tanaka A., Itoh H., Nishikawa H. Peripheral PAR-2 triggers thermal hyperalgesia and nociceptive responses in rats. Neuroreport. 12:2001;715-719.
9. Kawabata A., Kinoshita M., Nishikawa H., Kuroda R., Nishida M., Araki H., Arizono N., Oda Y., Kakehi K. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. Journal of Clinical Investigation. 107:2001;1443-1450.
10. Kawabata A., Kuroda R., Minami T., Kataoka K., Taneda M. Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. British Journal of Pharmacology. 125:1998;419-422.
11. Cocks T.M., Moffatt J.D. Protease-activated receptors: sentries for inflammation? Trends in Pharmacological Sciences. 21:2000;103-108.
12. Saifeddine M., Al-Ani B., Cheng C.-H., Wang L., Hollenberg M.D. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. British Journal of Pharmacology. 118:1996;521-530.
13. Corvera C.U., Dery O., McConalogue K., Bohm S.K., Khitin L.M., Caughey G.H., Payan D.G., Bunnet N.W. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. Journal of Clinical Investigation. 100:1997;1383-1393.
14. Cocks T.M., Sozzi V., Moffatt J.D., Selemidis S. Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle. Gastroenterology. 116:1999;586-592.
15. Kawabata A., Kuroda R., Nishikawa H., Kawai K. Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation. British Journal of Pharmacology. 128:1999;865-872.
16. Kawabata A., Kuroda R., Kuroki N., Nishikawa H., Kawai K. Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1. British Journal of Pharmacology. 131:2000;578-584.
17. Kawabata A., Kuroda R., Kuroki N., Nishikawa H., Kawai K., Araki H. Characterization of the protease-activated receptor-1-mediated contraction and relaxation in the rat duodenal smooth muscle. Life Sciences. 67:2000;2521-2530.
18. Kawabata A., Kuroda R., Nagata N., Kawao N., Masuko T., Nishikawa H., Kawai K. In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse. British Journal of Pharmacology. 133:2001;1213-1218.
19. Nguyen T.D., Moody M.W., Steinhoff M., Okolo C., Koh D.-S., Bunnett N.W. Trypsin activates pancreatic duct epithelial cell ion channels. Journal of Clinical Investigation. 103:1999;261-269.
20. Kawabata A., Morimoto N., Nishikawa H., Kuroda R., Oda Y., Kakehi K. Activation of protease-activated receptor-2 triggers mucin secretion in the rat sublingual gland. Biochemical and Biophysical Research Communications. 270:2000;298-302.
21. Kawabata A., Nishikawa H., Kuroda R., Kawai K., Hollenberg M.D. Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. British Journal of Pharmacology. 129:2000;1627-1632.
22. Kawabata A., Kuroda R., Morimoto N., Kawao N., Masuko T., Kakehi K. Lipopolysaccharide-induced subsensitivity of protease-activated receptor-2 in the mouse salivary glands in vivo. Naunyn-Schmiedeberg's archives of pharmacology. 364:2001;281-284.
23. Bohm S.K., Kong W., Bromme D., Smeekens S.P., Anderson D.C., Connolly A., Kahn M., Nelken N.A., Coughlin S.R., Payan D.G., Bunnett N.W. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochemical Journal. 314:1996;1009-1016.
24. 2+ entry and amylase secretion from the rat pancreas. Pflugers Archiv. 434:1997;25-37.
25. Lohinai Z., Burghardt B., Zellers T., Varga G. The effect of L-arginine/nitric oxide pathway on salivary amylase secretion in conscious rats. Journal of Physiology (Paris). 91:1997;217-221.
26. Ahn S.-H., Seo D.-W., Ko Y.-K., Sung D.-S., Bae G.-U., Yoon J.W., Hong S.-Y., Han J.-W., Lee H.-W. NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells. Archives of Pharmacal research. 21:1998;657-663.
27. Hanna S.J., Edwards A.V. The role of nitric oxide in the control of protein secretion in the parotid gland of anaesthetized sheep. Experimental physiology. 83:1998;533-544.
28. Lomniczi A., Suburo A.M., Elverdin J.C., Mastronardi C.A., Diaz S., Rettori V., McCann S.M. Role of nitric oxide in salivary secretion. Neuroimmunomodulation. 5:1998;226-233.
29. Vaquero E., Molero X., Puig-Divi V., Malagelada J.-R. Contrasting effects of circulating nitric oxide and nitrergic transmission on exocrine pancreatic secretion in rats. Gut. 43:1998;684-691.
30. Takeda Y., Krause J.E. Neurokinin K potently stimulates salivary gland secretion and potentiates substance P-induced salivation. Proceedings of National Academy of Sciences of U.S.A. 86:1989;392-396.
31. Folkers K., Feng D.-M., Asano N., Hakanson R., Weisenfield-Hallin Z., Leander S. Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity. Proceedings of National Academy of Sciences of U.S.A. 87:1990;4833-4835.
32. Pawlik W.W., Konturek S.J., Gustaw P., Czarnobilski K., Sendur R., Jaworek J., Yanaihara N. Role of tachykinins in the control of pancreatic secretion and circulation. Journal of Physiology and Pharmacology. 43:1992;41-55.
33. Kirkwood K.S., Kim E.H., He X.D., Calaustro E.Q., Domush C., Yoshimi S.K., Grady E.F., Maa J., Bunnett N.W., Debas H.T. Substance P inhibits pancreatic exocrine secretion via a neuronal mechanisms. Americal Journal of Physiology. 277:1999;G314-G320.
34. Niederau C., Nederau M., Luthen R., Strohmeyer G., Ferrell L.D., Grendell J.H. Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology. 99:1990;1120-1127.
35. Tachibana I., Kanagawa K., Yamamoto Y., Otsuki M. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function. Journal of Pharmacology and Experimental Therapeutics. 279:1996;1404-1412.
36. Hollenberg M.D., Saifeddine M., Al-Ani B., Kawabata A. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Canadian Journal of Physiology and Pharmacology. 75:1997;832-841.
37. 1 targeted ligands. Journal of Pharmacology and Experimental Therapeutics. 288:1999;358-370.
38. Kawabata A. Evidence that endogenous nitric oxide modulates plasma fibrinogen levels in the rat. British Journal of Pharmacology. 117:1996;236-237.
39. Damiano B.P., Cheung W.-M., Santulli R.J., Fung-Leung W.-P., Ngo K., Ye R.D., Darrow A.L., Derian C.K., Garavilla L.D., Andrade-Gordon P. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. Journal of Pharmacology and Experimental Therapeutics. 288:1999;671-678.
40. Barrachina M.D., Martinez V., Wang L., Wei J.Y., Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proceedings of National Academy of Sciences of U.S.A. 94:1997;10455-10460.
41. Molero X., Guarner F., Salas A., Mourelle M., Puig V., Malagelada J.R. Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: effects in acute pancreatitis. Gastroenterology. 108:1995;1855-1862.
42. Rettori V., Lomniczi A., Elverdin J.C., Suburo A., Faletti A., Franchi A., McCann S.M. Control of salivary secretion by nitric oxide and its role in neuroimmunomodulation. Annals of the New York Academy of Sciences. 917:2000;258-267.
43. Kawaguchi M., Yamagishi H. Receptive systems for drugs in salivary gland cells. Folia Pharmacologica Japonica. 105:1995;295-303.